Clinical presentation of COVID-19 in patients with inflammatory bowel disease: a systematic review and meta-analysis
Intestinal Research
; : 134-143, 2022.
Artigo
em Inglês
| WPRIM (Pacífico Ocidental)
| ID: wpr-914744
Biblioteca responsável:
WPRO
ABSTRACT
Background/Aims@#Coronavirus disease 2019 (COVID-19) is recognized to have variable clinical manifestations. The clinical presentation of patients with inflammatory bowel disease (IBD) having COVID-19 is unclear. @*Methods@#We identified articles reporting about the clinical presentation of COVID-19 in those with underlying IBD from PubMed and Embase. The studies, irrespective of design or language, were included. The overall pooled frequency of various symptoms was estimated. Joanna Briggs Institute Critical appraisal checklist was used to assess the quality of studies. @*Results@#Eleven studies, including 1,325 patients, were included in the pooled analysis. The pooled estimates for clinical presentation were; fever 67.53% (95% confidence interval [CI], 45.38–83.88), cough 59.58% (95% CI, 45.01–72.63), diarrhea 27.26% (95% CI, 19.51–36.69), running nose 27% (95% CI, 15.26–43.19) and dyspnea 25.29% (95% CI, 18.52–33.52). The pooled prevalence rates for abdominal pain, nausea and vomiting were 13.08% (95% CI, 9.24–18.19), 10.08% (95% CI, 5.84–16.85) and 8.80% (95% CI, 4.43–16.70) per 100 population, respectively. @*Conclusions@#The clinical presentation of COVID-19 in IBD patients is similar to the general population.
Texto completo:
Disponível
Contexto em Saúde:
Doenças Negligenciadas
Problema de saúde:
Diarreia
Base de dados:
WPRIM (Pacífico Ocidental)
Tipo de estudo:
Estudo prognóstico
/
Revisão sistemática
Idioma:
Inglês
Revista:
Intestinal Research
Ano de publicação:
2022
Tipo de documento:
Artigo